2025-06-16T09:11:15-05:00 2023-12-31 561031342 WILLIAMS OVERMAN PIERCE LLP 328 E MARKET STREET SUITE 100 GREENSBORO NC 27401 990 2023-01-01 812849764 GLIOBLASTOMA FOUNDATION INC GLIO 9193091489 2451 CROASDAILE FARM PARKWAY 109 DURHAM NC 27705 MADAN KWATRA SECRETARY/TREASURER 9193091489 2025-06-11 1 1 MARYELLEN PRANCE CPA P01662078 3362751686 2025-06-11 X 2023 2025-03-06 01:10:19Z MADAN KWATRA 2451 CROASDAILE FARM PARKWAY 109 DURHAM NC 27705 1699784 0 X WWW.GLIOBLASTOMAFOUNDATION.ORG X 2016 NC AS THE FIRST AND LEADING NATIONAL NONPROFIT DEVOTED TO GLIOBLASTOMA, THE MISSION OF THE GLIOBLASTOMA FOUNDATION IS TO FUND LEADING-EDGE RESEARCH FOR A CURE FOR GLIOBLASTOMA, PROVIDE PATIENT SUPPORT RESOURCES, AND RAISE AWARENESS OF THIS RARE, GRADE 4 BRAIN CANCER. AS A NATIONAL NONPROFIT DEVOTED TO GLIOBLASOMA, GLIOBLASTOMA FOUNDATION FUNDS TARGETED RESEARCH FOR NEW, MORE EFFECTIVE TREATMENTS BASED ON THE MOLECULAR FEATURES OF A PATIENT'S TUMOR. OUR MISSION IS TO TRANSFORM GLIOBLASTOMA FROM TERMINAL TO TREATABLE. BECAUSE EACH GLIOBLASTOMA TUMOR IS DIFFERENT A TARGETED APPROACH IS NEEDED TO CURE THIS DISEASE. WE ALSO PROVIDE PATIENT SUPPORT SERVICES AT THE GLIOBLATOMA FOUNDATION TO HELP PATIENTS AND FAMILIES AFTER THEY RECEIVE A GLIOBLASTOMA DIAGNOSIS. FOR PATIENTS DIAGNOSED WITH THE DISEASE, WE OFFER CLINICAL TRIALS MATCHING AND A PROFESSIONALLY-LED SUPPORT GROUP FOR CAREGIVERS AND PATIENTS. LASTLY, WE WORK TO RAISE AWARENESS OF GLIOBLASTOMA, SO THAT THE FIRST TIME SOMEONE HEARS THE WO 5 4 14 0 0 0 1513382 1691690 0 0 -41832 8094 0 0 1471550 1699784 180000 245000 0 0 262769 516096 0 0 56416 410809 650396 853578 1411492 617972 288292 1781399 2482026 0 0 1781399 2482026 X AS THE FIRST AND LEADING NATIONAL NONPROFIT DEVOTED TO GLIOBLASTOMA, THE MISSION OF THE GLIOBLASTOMA FOUNDATION IS TO FUND RESEARCH FOR TARGETED TREATMENTS FOR GLIOBLASTOMA, PROVIDE SUPPORT PATIENTS AND FAMILIES AFTER A GLIOBLASTOMA DIAGNOSIS, AND TO RAISE AWARENESS OF THIS RACE, GRADE 4 BRAIN CANCER. 0 0 1216828 245000 THE RESEARCH ACHIEVEMENTS OF THE GLIOBLASTOMA FOUNDATION IN 2023 INVOLVED CONTINUING FUNDING FOR LEADING EDGE RESEARCH FOR TARGETED TREATMENTS FOR GLIOBLASTOMA, PROVIDING PATIENT SUPPORT RESOURCES FOR FAMILIES AND PATIENTS DIAGNOSED WITH GLIOBLASTOMA, AND RAISING AWARENESS OF THIS RARE GRADE 4 BRAIN CANCER. DURING THE 2023 YEAR WE CONTINUED TO FUND RESEARCH FOR THE COMBINATION DRUG THERAPY OF LOMUSTINE AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS, FUNDED RESEARCH INTO PATIENT AND CAREGIVER QUALIFY OF LIFE AFTER DIAGNOSIS RESEARCH, AND A TARGETED RESEARCH STUDY ON GLIOBLASTOMA CANCER CELL METABOLISM PROCESSES AND DRUGS TO STOP GLIOBLASTOMA CELL GROWTH. WE ALSO MOVED FORWARD ON OUR GOAL TO MANUFACTURE LOMUSTINE AT A REDUCED RATE FOR PATIENTS BY PARTNERING WITH CONTINUITY PHARMA IN THE PRODUCTIVE OF LOMUSTINE ACTIVE PHARMACEUTICAL INGREDIENT. THIS PROJECT IS CURRENTLY UNDERWAY TO BRING LOMUSTINE TO PATIENTS AT A LOWER COST. WE ALSO CONTINUED OUR PATIENT PROGRAMS TO PROVIDE CLINICAL TRIALS MATCHING TO PATIENTS AFTER A GLIOBLASTOMA DIAGNOSIS AND CONTINUED TO HOST OUR AWARD-WINNING SUPPORT GROUP FOR PATIENTS AND CAREGIVERS, CALLED THE GLIOBLASTOMA SUPPORT CIRCLE. 1216828 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 14 1 0 0 0 0 0 0 0 0 0 0 0 0 X 5 4 1 0 0 0 0 0 0 1 1 1 0 1 1 1 1 1 1 1 0 0 X MADAN KWATRA 9194021775 2451 CROASDAILE FARM PARKWAY 109 DURHAM NC 27705 NEELAM KWATRA PRESIDENT 20.00 X X 0 0 0 MADAN KWATRA TREASURER/SECRETARY 4.00 X X 0 0 0 GITA KWATRA CEO 40.00 X X 300000 0 36015 CAMERON WEST BOARD MEMBER 1.00 X X 0 0 0 BRIAN AUSTIN BOARD MEMBER 1.00 X 0 0 0 300000 0 36015 1 0 1 0 0 1691690 1691690 8094 8094 1699784 0 0 8094 245000 245000 336015 319218 16797 134578 127849 6729 45503 43228 2275 28196 28196 56416 56416 269209 269209 21563 21563 36293 36293 74324 74324 17988 17988 1176 1176 CONTRACT SERVICES 83719 83719 FACILITIES AND EQUIPMEN 23880 23880 MISCELLANEOUS 18494 18494 BANK FEES 9183 9183 9955 9955 1411492 1216828 138248 56416 1034846 1025929 18250 18250 8837 2570 3896 6267 724407 1431580 1781399 2482026 0 0 X 1781399 2482026 1781399 2482026 1781399 2482026 288292 399730 12605 0 X X 1 X 0 1 0 X 448677 842093 1302093 1513382 1691690 5797935 448677 842093 1302093 1513382 1691690 5797935 5797935 4227 9185 14333 8094 35839 5833774 0.99390 0.99380 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 8837 2570 6267 6267 ETRADE 1431580 F 1431580 1 DUKE UNIVERSITY HOSPITAL PO BOX 90581 DURHAM NC 27708 560532129 75000 0 GLIOBLASTOMA RESEARCH TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 615 W 131ST STREET 8741 NEW YORK NY 10027 911859360 100000 0 GLIOBLASTOMA RESEARCH MASS GENERAL HOSPITAL 125 NASHUA STREET SUITE 540 BOSTON MA 02114 041564655 30000 0 GLIOBLASTOMA RESEARCH YALE UNIVERSITY 157 CHURCH STREET NEW HAVEN CT 16510 060646973 30000 0 GLIOBLASTOMA RESEARCH 4 X 0 0 0 0 0 0 0 0 0 GITA KWATRA CEO 300000 0 0 0 0 0 22500 0 13515 0 336015 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 THREE BOARD MEMBERS, WHO ARE THE ORGANIZATION'S FOUNDERS, ARE FAMILY MEMBERS. FORM 990, PART VI, SECTION B, LINE 11B THE FORM 990 IS AVAILABLE TO THE ORGANIZATION'S ENTIRE GOVERNING BODY AND BOARD MEMBERS. FORM 990 IS REVIEWED BY THE ORGANIZATION'S PRESIDENT AND TREASURER BEFORE IT IS FILED WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C EMPLOYEES AND DIRECTORS ARE REQUIRED TO DISCLOSE CONFLICT OF INTERESTS WHEN THEY ARISE AND ARE REQUIRED TO FILE AN ANNUAL DISCLOSURE FORM. FORM 990, PART VI, SECTION B, LINE 15A COMPENSATION IS IN ACCORDANCE WITH NATIONAL STANDARDS BASED ON THE EDUCATION OF THE OFFICER. FORM 990, PART VI, SECTION C, LINE 18 TAX RETURNS ARE AVAILABLE FOR PUBLIC INSPECTION ONLINE AT IRS.GOV AND PROPUBLICA.ORG. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S CONFLICT OF INTEREST POLICY IS AVAILABLE UPON REQUEST. FORM 990, PART VII CONTACT ADDRESSES FOR OFFICERS, DIRECTORS, ETC CAMERON WEST - 517 E 30TH AVE, HUTCHINSON, KS 67502. BRIAN AUSTIN - 900 FIELD CLUB RD, PITTSBURGH, PA 15238. FORM 990, PART XII, LINE 2C: THIS PROCESS HAS NOT CHANGED FROM THE PRIOR YEAR.